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Abstract
The acute respiratory distress syndrome (ARDS) is common in critically ill
patients and has a high mortality rate. Mesenchymal stromal cells (MSCs)
have demonstrated therapeutic potential in animal models of ARDS, and their
benefits occur in part through interactions with alveolar type II (ATII) cells.
However, the effects that MSCs have on human ATII cells have not been well
studied. Using previously published microarray data, we performed genome-
wide differential gene expression analyses of human ATII cells that were (1)
unstimulated, (2) exposed to proinflammatory cytokines (CytoMix), or (3)
exposed to proinflammatory cytokines plus MSCs. Findings were validated by
qPCR. Alveolar type II cells differentially expressed hundreds of genes when
exposed either to proinflammatory cytokines or to proinflammatory cytokines
plus MSCs. Stimulation with proinflammatory cytokines increased expression
of inflammatory genes and downregulated genes related to surfactant function
and alveolar fluid clearance. Some of these changes, including expression of
some cytokines and genes related to surfactant, were reversed by exposure to
MSCs. In addition, MSCs induced upregulation of other potentially beneficial
genes, such as those related to extracellular matrix remodeling. We confirmed
several of these gene expression changes by qPCR. Thus, ATII cells downregu-
late genes associated with surfactant and alveolar fluid clearance when exposed
to inflammatory cytokines, and mesenchymal stromal cells partially reverse
many of these gene expression changes.
Introduction
The acute respiratory distress syndrome (ARDS) is com-
mon, affecting approximately 10% of adult intensive care
unit patients worldwide (Bellani et al. 2016). With an in-
hospital mortality of almost 40% for ARDS (Rubenfeld
et al. 2005) and a lack of disease-modifying therapies
(Laffey and Matthay 2017), developing new treatments
are important (Thompson et al. 2017).
Pathologically, ARDS is characterized by injury to the
lung parenchyma, which is due in part to an immune
response (Laffey and Matthay 2017). Mesenchymal
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stromal cells (MSCs) have significant therapeutic poten-
tial in ARDS through their anti-inflammatory effects and
barrier enhancing effects (Laffey and Matthay 2017; Mat-
thay et al. 2017), and they are currently the focus of clin-
ical trials for ARDS, sepsis, and bronchopulmonary
dysplasia. These self-renewing multipotent stem cells have
shown benefits in several preclinical studies (Laffey and
Matthay 2017). MSCs reduce pulmonary edema and the
inflammatory responses to endotoxin in mouse models of
ARDS (Gupta et al. 2007). They improve animal survival
in part through the release of proresolving lipids (Fang
et al. 2010) and anti-inflammatory proteins, such as the
IL-1 receptor antagonist (Ortiz et al. 2007). MSCs are
known to interact with several types of immune cells (Li
et al. 2008; Spaggiari et al. 2006; Zappia et al. 2005).
Recently, they were also shown to interact with alveolar
type II (ATII) cells (Fang et al. 2010, 2015), attenuating
the increased protein permeability and cytoskeletal
changes that proinflammatory cytokines induce in cul-
tured ATII cell monolayers (Fang et al. 2010). These
effects were mediated by MSC-dependent angiopoietin-1
secretion, suggesting a vascular-mediated mechanism by
which they could reduce lung injury and pulmonary
edema.
ATII cells make up approximately 2–5% of the alveolar
surface area (Jansing et al. 2017) and have several impor-
tant functions. They produce surfactant, serve as progeni-
tor cells for the alveolar epithelium (Barkauskas et al.
2013) thus helping restore epithelial barriers (Jansing
et al. 2017), and play a key role in vectorial sodium-
dependent transport of fluid to maintain dry airspaces
(Matthay 2014; Matthay et al. 2002). Progenitor function
is regulated by EGFR-KRAS (Desai et al. 2014), Wnt/b-
catenin (Nabhan et al. 2018; Zemans et al. 2011), ker-
atinocyte growth factor (KGF), and hepatocyte growth
factor (HGF) (Ware and Matthay 2002) signaling. ATII
cells also play a role in host defense through cytokine and
chemokine expression (Thorley et al. 2007) and by pro-
ducing surfactant proteins A and D, which are collectins
that opsonize microorganisms (Haczku 2008). However,
ATII cell responses both to inflammatory environments
and to MSCs are incompletely understood, and their
response to MSCs has not been studied on a genome-
wide level.
The objective of this study was to elucidate how MSCs
affect epithelial cell biology in an inflammatory environ-
ment. Using previously published microarrays (Fang et al.
2015), we performed an unbiased, genome-wide explora-
tory analysis of human ATII cell gene expression in
response to stimulation with proinflammatory cytokines
in the presence or absence of MSCs. We first examined
the gene expression of ATII cells exposed to CytoMix (a
mixture of TNF-a, IL-1b, and IFN-c), which models the
proinflammatory edema fluid of ARDS (Lee et al. 2007).
We also studied the gene expression of ATII cells cocul-
tured with human bone marrow-derived MSCs and stim-
ulated with CytoMix. We confirmed many of the gene
expression changes with qPCR.
In response to CytoMix, ATII cells upregulated cytoki-
nes and downregulated genes that code for proteins
related to surfactant and alveolar fluid clearance. Expo-
sure to MSCs plus CytoMix partially reversed some of the
gene expression changes induced by CytoMix.
Materials and Methods
Cell cultures and transwell system
The microarray data used in this study were from a pre-
viously described experiment of ATII and MSCs (Fang
et al. 2015). The ATII cells for the microarray were iso-
lated from cadaver human lung tissues of five adult males
with no lung disease using previously published methods
(Fang et al. 2010), and the ATII cells used for quantita-
tive PCR (qPCR) validation were harvested from a differ-
ent donor using the same methods. The lungs were
harvested from brain-dead subjects, maintained at 4°C,
and transported to the University of California, San Fran-
cisco within 6 h. Within 24 h of arrival in our labora-
tory, the ATII cells were isolated from the right middle
lobe, if there was no evidence of injury or consolidation
to that lobe. Allogeneic human MSCs were obtained from
the Tulane Center for Gene Therapy (New Orleans, LA)
for microarray studies and from the Institute for Regen-
erative Medicine at the Texas A&M Health Science Cen-
ter for qPCR studies. The ATII cells were plated at a
density of 1 9 106 cells/well in the upper compartment
of Transwell systems (0.4-mm pore size and collagen I
coated; Costar, Corning). The Transwell system was used
to study the paracrine effects of MSCs on ATII cells
(Huppert and Matthay 2017). As previously described
(Fang et al. 2010), the cells were cultured in a 37°C and
5% CO2 incubator in mixed media of DMEM high glu-
cose 50% and F-12 50% containing 10% FBS and
antibiotics (gentamicin, penicillin, streptomycin, and
amphotericin). Where indicated, CytoMix (IL-1b, TNF-a,
and IFN-c, 50 ng/mL each; R&D Systems) was added to
the culture medium, and MSCs were plated in the bot-
tom compartment of the Transwell at a density of
250,000 cells/well with no direct contact with ATII cells,
as described previously (Fang et al. 2015). ATII cells,
MSCs, and CytoMix were added simultaneously, and
conditions were maintained for 24 h (Fang et al. 2015).
Three conditions were examined: (1) ATII cells alone
(control), (2) ATII cells plus CytoMix, and (3) ATII cells
plus MSCs and CytoMix.
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Microarray data processing
The gene expression data used for this study were previ-
ously published (Fang et al. 2015) and made publicly avail-
able as GSE68610 on the Gene Expression Omnibus (GEO)
(Edgar et al. 2002). These data were generated using Affy-
metrix Human Genome U133A 2.0 Arrays. We down-
loaded the raw data from GEO and processed them using
the Robust Multi-array Average, or RMA (Irizarry et al.
2003). Only four arrays were available for ATII cells
exposed to CytoMix but not MSCs, but five arrays were
available for the other conditions. No batch correction was
performed because all array experiments were done in a
single batch. During data processing, we applied a custom
cell description file (CDF) as provided by the Microarray
Lab at the University of Michigan (Dai et al. 2005). Cus-
tom CDFs were used to ensure that probe set annotations
were updated. This method excludes probes that do not
match a gene sequence perfectly and uniquely, which may
reduce the number of genes used for comparisons (Dai
et al. 2005). We used custom CDF version 21 and specifi-
cally a CDF that summarizes gene expression data to Entrez
Gene Identifiers. We did not exclude any gene based on its
level of expression in the dataset. For quality control, we
also checked interarray Pearson correlation within each of
the three conditions, using a cut-off of below 0.90 to con-
sider an array for exclusion. Replicate arrays demonstrated
within-condition correlation of at least 0.94.
Quantitative PCR
Using qPCR, we validated differential expression for genes
that had statistically significant expression changes and
were of interest because of their biological functions. Total
RNA from ATII cells was isolated with the RNeasy Mini kit
(Qiagen) and reverse transcribed to cDNA using the “High
Capacity RNA-to-cDNA Kit” (Applied Biosystems). The
assay IDs for TaqMan specific gene primers (Applied
Biosystems) were: SFTPB (Hs00167036_m1), SFTPD (Hs0
1108490_m1), IL23A (Hs00372324_m1), CCL2 (Hs00234
140_m1), AQP1 (Hs01028916_m1), AQP3 (Hs001850
20_m1), AQP5 (Hs00387048_m1), CXCL10 (Hs001710
42_m1), CXCL11 (Hs00171138_m1), POSTN (Hs01566
750_m1), LOX (Hs00942480_m1), CASP8 (Hs01018
151_m1), SCNN1A (Hs00168906_m1), SCNN1B (Hs0154
8617_m1), GAPDH (Hs02786624_g1), and EIF2B2
(Hs00204540_m1). qPCR was performed with TaqMan
gene primers and TaqMan Fast Advanced Master Mix
(Applied Biosystems) using the StepOnePlus System
(Applied Biosystems). The average threshold count (Ct)
value of three technical replicates was used in all calcula-
tions. GAPDH and EIF2B2 were used as a housekeeping
genes because they displayed the lowest standard deviation
among groups compared to other housekeeping genes
tested. Data analysis was performed using the 2DCt
method (Schmittgen and Livak 2008). Relative mRNA data
are expressed as mean  standard deviation.
Statistical analyses
All statistical analyses were performed using R version
3.3.2. We performed principal component analysis using
the “prcomp” function in R and hierarchical clustering
using tools from the Bioconductor package made4 (Cul-
hane et al. 2005). Gene symbols and descriptions for each
gene were generated using the “getBM” function from the
biomaRt package in R, and orthologous gene lists
between species were generated using the “getLDS” pack-
age in biomaRt (Durinck et al. 2009). We excluded arrays
that appeared to be outliers based on hierarchical cluster-
ing and principal component analysis. We performed dif-
ferential gene expression analysis using the Bioconductor
package limma (Ritchie et al. 2015), and we focused on
two comparisons: (1) ATII cell controls versus ATII cells
exposed to CytoMix, and (2) ATII cells exposed to Cyto-
Mix versus ATII cells exposed to both CytoMix and
MSCs. Genes were considered differentially expressed if
they were at least twofold differentially expressed between
conditions and if the P-value was <0.05 after adjusting
for multiple testing using the Benjamini–Hochberg
method (Benjamini and Hochberg 1995).
For gene set enrichment analysis of up- and downregu-
lated genes, we used gene sets that were downloaded from
MSigDB (Subramanian et al. 2005) to look for functional
enrichment. P-values for enrichment were generated in R
using Fisher’s exact test, where the number of genes in
our processed microarray dataset was the background
number. We adjusted Fisher’s exact test P-values for mul-
tiple testing using the Benjamini–Hochberg method (Ben-
jamini and Hochberg 1995). We used the “Hallmark”
gene sets (Liberzon et al. 2015) from MSigDB in the ini-
tial exploratory analyses. “Hallmark” gene sets are derived
from published gene sets and describe specific biological
states. They were developed in order to reduce hetero-
geneity and redundancy among descriptive gene sets
(Liberzon et al. 2015). We also downloaded the “Canoni-
cal pathway” gene sets from MSigDB, which are curated
from pathway databases, such as KEGG (Kanehisa and
Goto 2000) or Reactome (Croft et al. 2014).
Hierarchical clustering dendrograms and heatmaps
were created using the “heatplot” function in the Biocon-
ductor pathway made4 (Culhane et al. 2005). Hierarchical
clustering was performed with distance function 1-Pear-
son correlation, as previously done (Eisen et al. 1998).
We visualized KEGG pathways using the pathview pack-
age in Bioconductor (Luo and Brouwer 2013).
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Results
Mesenchymal stromal cells and CytoMix
both modulate ATII cell gene expression
We analyzed a total of 12,264 genes in ATII cells derived
from human lungs of five individuals. Principle compo-
nent analysis revealed that most of the gene expression
variation (61%) in this dataset could be explained by
two principal components (Fig. 1A). The first compo-
nent (50% of variation) separated ATII cells that were
exposed or unexposed to MSCs, and the second (11% of
variation) separated ATII cells exposed to only CytoMix
from control ATII cells and ATII cells exposed to both
CytoMix and MSCs. This suggests that CytoMix and
MSCs had independent effects on ATII cell gene expres-
sion. For future analyses, we removed one outlier array
based on the principal component analysis and
hierarchical clustering analysis (Fig. 1). This ATII repli-
cate exposed to only CytoMix clustered with control
ATII cells, suggesting that the CytoMix was ineffective in
this sample.
CytoMix induces alveolar type II cells to
upregulate proinflammatory genes and
downregulate genes required for surfactant
production and alveolar fluid clearance
A total of 409 and 454 genes were up- and down regu-
lated, respectively, in ATII cells in response to CytoMix
(Table S1). Upregulated genes were enriched for several
MSigDB Hallmark gene sets and pathways related to
inflammation (Fig. 2, Table S2). These include gene sets
describing response to TNF-a via NF-jB signaling (en-
richment adjusted P-value 8 9 1063) and response to
interferon gamma (P = 1 9 1073). For example, the
Figure 1. (A) Principle component analysis of all arrays in the type
II alveolar cell microarray dataset. (B) Hierarchical clustering of all
arrays in the dataset using all genes on the arrays.
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Figure 2. Gene set enrichment of differentially expressed genes.
(A) MSigDB Hallmark gene sets upregulated in alveolar type II (ATII)
cells exposed to CytoMix. (B) MSigDB Hallmark gene sets
upregulated in ATII cells exposed to mesenchymal stromal cells and
CytoMix compared to CytoMix alone.
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most strongly upregulated genes included those encoding
chemokines CXCL10 and CXCL11 (Fig. 3), both of which
are upregulated over 100-fold and are known to be
induced by interferon gamma (Kanda et al. 2007). Genes
coding CCL5, CCL7, and CCL8 were also upregulated, as
was IL1b. Of the canonical pathways, the Reactome
cytokines pathway is the most statistically significantly
upregulated (P = 2 9 1020, Table S1). Using the “path-
view” function in Bioconductor (Luo and Brouwer 2013),
we also visualized up- and downregulated genes within
the KEGG TNF pathway. Many elements of the TNF
pathway were upregulated, as were numerous cytokines
and chemokines (Fig. 4).
Gene sets downregulated in ATII cells following exposure
to CytoMix were related to lipid metabolism and alveolar
fluid transport. The most enriched MSigDB Hallmark gene
set was adipogenesis (P = 4 9 106, Table S3), which
includes genes coding for proteins important for pul-
monary surfactant function, such as long chain Acyl-CoA
dehydrogenase (Goetzman et al. 2014). Surfactant proteins
B and D were downregulated 23- and 10-fold, respectively
(Fig. 3). Downregulated genes also included those involved
in ion and water channel function (Fig. 3, Table S1). The
alpha and beta subunits of epithelial sodium channel
(ENaC) were not differentially expressed in the initial gen-
ome-wide analysis adjusted for multiple testing. However,
given the importance of the ENaC channel to alveolar fluid
clearance (Matthay 2014), we carried out focused, hypothe-
sis-driven statistical testing without multiple testing adjust-
ment. We found that genes encoding both ENaC alpha and
beta subunits were downregulated (P = 6 9 105 and
0.03, respectively).
Mesenchymal stromal cells alter multiple
aspects of ATII gene expression
Exposure of ATII cells to CytoMix plus MSCs resulted in
the upregulation of 215 and downregulation of 938 genes
compared to CytoMix alone (Table S4).
Functional enrichment analysis identified various
upregulated genes involved in epithelial-mesenchymal
transition (P = 2 9 1011, Fig. 2, Table S5). For example,
we identified upregulation of SNAIL (adjusted P = 0.0
05), and downregulation of E-cadherin (adjusted
P = 0.001). However, several EMT genes (Lamouille et al.
2014) were not differentially expressed, such as genes cod-





Figure 3. Heatmap of genes differentially expressed by type II alveolar cells (ATII). We included genes differentially expressed when ATII cells were
exposed to either CytoMix or to CytoMix plus mesenchymal stromal cells in a Transwell system. The top 10 most up- and downregulated genes in
each comparison are displayed. Red and blue indicate increased and decreased expression, respectively, normalized to a z-score for each gene.
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A  TNF pathway genes altered with CytoMix
B  TNF pathway genes altered with MSCs
Figure 4. Differential expression of TNF pathway genes. Figures were generated using the “pathview” package in Bioconductor (Luo and
Brouwer 2013). Red means upregulated and green means downregulated. (A) Genes from the KEGG (Kanehisa and Goto 2000) TNF pathway
that are differentially expressed in ATII cells exposed to CytoMix compared to control. (B) Genes from the KEGG TNF pathway that are
differentially expressed in ATII cells exposed to mesenchymal stromal cells and CytoMix compared to CytoMix alone.
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Among the genes in this Hallmark gene set, two of the
most strongly upregulated were genes coding for periostin
and lysyl oxidase (Table S4), proteins involved in collagen
cross-linking (Maruhashi et al. 2010) (Fig. 3), which sug-
gests extracellular matrix modification. Consistently, the
canonical pathways that were most enriched in these
upregulated genes included several pathways related to the
extracellular matrix (Table S5). Genes coding for fibronec-
tin and matrix metalloproteinases were also strongly upreg-
ulated, consistent with wound healing and repair.
To further analyze the ATII cells’ reparative potential, we
examined differential expression of other factors, such as
EGFR (Desai et al. 2014) and genes related to Wnt signaling
(Nabhan et al. 2018; Zemans et al. 2011). Although several
of these genes did not meet our original cutoff of fold-
change >2, EGFR, WNT2, WNT8B, WNT10B, WNT11, and
WNT16 were all significantly upregulated (P < 0.05, after
multiple testing adjustment) with MSC exposure. Some
genes related to proliferation, such as KI67, E2F1, E2F2, and
E2F4, were similarly upregulated, although other genes
related to proliferation, such as MYC signaling (Table S7),
were downregulated. Lastly, we noted increased expression
of angiopoeitin-1, which helps restore more normal ATII cell
paracellular permeability to protein (Fang et al. 2010), and
nearly significantly increased HGF expression (P = 0.052),
which also helps with repair (Ware and Matthay 2002).
Although MSC exposure was associated with upregula-
tion of some genes related to TNF-a signaling (Fig. 2,
Table S5), the specific pathway genes were different from
those upregulated with CytoMix exposure (Table S6). Fig-
ure 4 shows that several genes from the KEGG TNF path-
way were downregulated with MSC exposure, particularly
chemokines, suggesting that MSCs have an anti-inflam-
matory effect. Genes associated with apoptosis such those
coding for FADD and caspase proteins and the Reactome
apoptosis pathway (Table S7) were also downregulated,
suggesting an antiapoptotic effect of MSCs on ATII cells.
Similarly, genes coding for other antiapoptotic proteins,
such as SODD or CHOP, were upregulated, with DDIT3,
the gene that codes for CHOP, being eightfold increased
and the fifth most strongly upregulated gene. The TNF-a
pathway genes upregulated by MSCs but not by CytoMix
also included several coding for transcription factors such
as HES1, FOS, JUNB, and KLF2, the last of which is
essential for type 1 pneumocyte differentiation during
development in mice (Pei et al. 2011), a process also
important for lung injury repair (Jansing et al. 2017).
MSCs attenuate inflammatory changes
induced by CytoMix
In genome wide analyses adjusted for multiple testing,
genes upregulated by CytoMix were significantly
downregulated by MSCs (Fisher’s test P = 7 9 1011),
and those downregulated by CytoMix were also signifi-
cantly upregulated by MSCs (P = 6 9 109). Genes with
transcriptional changes induced by CytoMix and reversed
by exposure to MSCs included those coding surfactant
protein B, IL-23, and CCL2, which is a chemokine
involved in ARDS pathogenesis (Williams et al. 2017)
(Table S8). In hypothesis-driven tests for genes that we
found were downregulated by CytoMix, we also found
that the alpha and beta subunits of ENaC were upregu-
lated with MSC exposure (P = 0.01 and 4 9 105,
respectively).
Notably, not all genes related to inflammation were
reversed following 24 h of MSC exposure. For example,
ATII cells are known to express pattern recognition recep-
tors (PRR) (Evans et al. 2010); several of these were
upregulated by CytoMix but their expression did not
change in response to MSCs. For example, NOD2, which
is a PRR expressed by epithelial cells (Uehara et al. 2007),
was upregulated over 3-fold in response to CytoMix and
remained upregulated in cells exposed to CytoMix plus
MSCs. A similar pattern was observed for DDX58, the
gene coding for the PRR RIG-I. The only Toll-like recep-
tor (TLR) that was downregulated with MSC exposure in
our initial analysis was TLR3 (Table S4).
Comparison of MSC effects to those from a
mouse model
In order to validate these differentially expressed genes,
we examined comparable differentially expressed genes
from a mouse model (dos Santos et al. 2012). In dos San-
tos et al. (2012), mice underwent cecal ligation with or
without exposure to MSCs, and differential gene expres-
sion analysis of several murine tissues, including the lung,
was performed. We found that 33% of the genes that
were differentially expressed in ATII cells exposed to
MSCs (Table S4) overlapped with those from dos Santos
et al. (Fisher’s test P = 0.0004), suggesting that the MSCs
affected similar pathways in both models. The downregu-
lated genes had particularly strong overlap with those
downregulated in dos Santos et al. (19%, P = 4 9 106),
with similar downregulation of caspase 3 and chemokine
ligands CXCL1, CXCL2, CXCL3, and CCL4. The upregu-
lated genes were under-enriched in those upregulated in
dos Santos et al. (4%, P = 0.005).
Validation with quantitative PCR
For the genes tested, all gene expression changes induced
by CytoMix were confirmed with qPCR (Fig. 5). CytoMix
induced upregulation of genes coding for several cytoki-
nes, including CXCL10, CXCL11, CCL2, and IL-23, and it
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Figure 5. Quantitative PCR validation. Gene expression changes in ATII cells for several genes across three conditions: control, exposure to
CytoMix, and exposure to both CytoMix and MSCs. Gene expression values are from qPCR, normalized to reference gene GAPDH. The genes
featured are those coding for (A) ENaC subunit alpha, (B) ENaC subunit beta, (C) Caspase 8, (D) Periostin, (E) Lysyl oxidase, (F) IL-23, (G)
CXCL10, (H) CXCL11, (I) CCL2, (J) Aquaporin 1, (K) Aquaporin 3, (L) Aquaporin 5, (M) Surfactant protein B, (N) Surfactant protein D.
2018 | Vol. 6 | Iss. 16 | e13831
Page 8
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
Effects of MSCs on ATII Inflammatory Responses M. Schwede et al.
induced downregulation of genes coding for surfactant
protein B, surfactant protein D, and the ENaC subunits
alpha and beta.
The effects of MSCs were not all confirmed with qPCR,
but the gene expression trends were overall similar to those
of the microarray. Exposure to MSCs resulted in downreg-
ulation of CXCL10, CXCL11, and caspase 8, but IL-23 was
not substantially downregulated, and CCL2 was actually
upregulated with MSC exposure by qPCR. Additionally,
surfactant protein D and ENaC beta expression increased
with MSC exposure, but surfactant protein B and ENaC
alpha expression remained unchanged. MSCs caused
increased gene expression of lysyl oxidase and periostin,
similar to the microarray results. Interestingly, in the
microarray analysis, surfactant protein D, CXCL10, and
CXCL11 were not differentially expressed with MSC plus
CytoMix compared to CytoMix alone (P > 0.10 for those
comparisons).
Discussion
The primary findings of this study can be summarized as
follows. Several gene expression pathways in ATII cells
were modified in response to a mixture of TNF-a, IL-1b,
and IFN-c, which models the proinflammatory edema
fluid of ARDS (Lee et al. 2007). MSCs reversed some, but
not all of the effects of CytoMix on ATII cells, including
upregulation of inflammatory genes and downregulation
of genes related to key ATII cell functions, such as surfac-
tant production and alveolar fluid clearance.
ATII cells exposed to CytoMix upregulated genes cod-
ing several cytokines and proapoptotic proteins. It has
been previously shown that ATII cells can express cytoki-
nes in infection or inflammatory environments (Stege-
mann-Koniszewski et al. 2016). In response to CytoMix,
ATII cells also downregulated genes important for normal
ATII cell function, such as genes related to surfactant and
vectorial alveolar fluid transport. Consistently, previous
studies have shown that the inflammatory environment
induced by endotoxin reduced the surfactant production
in mice (Islam et al. 2012) and alveolar fluid clearance in
the human lung (Lee et al. 2009). In addition, several
genes related to lipid production and genes encoding sur-
factant B, which is important for maintaining alveolar
tension (Whitsett et al. 1995), and surfactant D, which is
thought to support host defense in the alveolus (Hartl
and Griese 2006), were downregulated. Genes important
for fluid transport were also downregulated, such as those
coding for the alpha and beta subunits of ENaC. CytoMix
was previously shown to induce downregulation of ENaC
subunits alpha and beta in ATII cells (Lee et al. 2007).
In contrast, MSCs induced ATII cells to reverse some
of the gene expression changes induced by CytoMix. With
MSCs, ATII cells upregulated the genes coding surfactant
protein D and ENaC subunit beta while they downregu-
lated gene expression for genes associated with apoptosis,
such as caspase 8, and cytokines, such as CXCL10, which
has been linked to ARDS pathogenesis (Ichikawa et al.
2013).
Our research group has previously reported that MSCs
partially restore fluid clearance in injured lung through
ENaC-mediated sodium transport (Lee et al. 2009). While
the effect of MSCs on ENaC alpha did not validate with
qPCR, ENaC activity in alveolar cells may also change
independent of gene or protein expression (Planes et al.
2002). The same is true for caspases, where posttransla-
tional modification alters their catalytic activity (Zama-
raev et al. 2017).
MSCs also induced ATII cells to upregulate several
genes, including those in pathways related to injury repair
and the epithelial–mesenchymal transition. The signifi-
cance of epithelial–mesenchymal transition genes is
unclear because many other genes associated with epithe-
lial–mesenchymal transition were not differentially
expressed. However, the most strongly upregulated of
these genes were related to extracellular matrix modifica-
tion. For example, ATII cells exposed to MSCs upregu-
lated the gene coding for periostin, which has been
shown to enhance wound repair in alveolar epithelial cells
(Akram et al. 2013). Periostin also causes airway fibrob-
lasts to overexpress collagen and helps stiffen the collagen
matrix (Sidhu et al. 2010), making it potentially beneficial
for epithelial repair. Consistently, several genes related to
repair, such as EGFR, angiopoietin-1, and HGF were also
statistically significantly up-regulated.
MSCs did not reverse all genes associated with CytoMix
exposure, including genes that could be relevant for host
defense, such as PRR. TLR3 was downregulated with
MSC exposure, but this may be advantageous since
TLR3-deficient mice with influenza have a survival advan-
tage, potentially because of an attenuated inflammatory
response (Le Goffic et al. 2006).
Most of our findings validated with qPCR, which is
expected using arrays and data processing methods simi-
lar to our own (Dallas et al. 2005). In our experiment, a
few gene expression changes in the microarray analyses
were not validated by qPCR, particularly those related to
MSC exposure. For example, with MSC exposure, chemo-
kine CCL2 gene expression increased in the qPCR analysis
but decreased in the microarray analysis. Several factors
may have contributed to discrepancies between microar-
ray and qPCR, including biological variability. The qPCR
was performed using a new ATII biological replicate, and
genes used for qPCR were in part chosen because of bio-
logical interest, not always because of magnitude of differ-
ential expression. The qPCR studies were also performed
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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using MSCs derived from an individual different from
those in the original microarray. Regardless, most of the
trends related to MSC exposure were confirmed with
qPCR, such as reduced ATII cytokine gene expression
and increased gene expression associated with alveolar
fluid clearance and surfactant. It is also possible that dif-
ferent MSC experiments alter similar transcriptional pro-
grams but potentially different genes. This is further
supported by the significant overlap of these genes differ-
entially expressed in ATII cells and genes differentially
expressed in a mouse model of sepsis, in which mice were
also exposed to MSCs (dos Santos et al. 2012).
Our study has several advantages. Genome-wide analy-
sis of human ATII cells exposed to human mesenchymal
stromal cells in an inflammatory milieu is novel and
allowed us to identify previously unexplored changes in
ATII cells. Our study offers the added benefit of enriching
for the low abundance ATII cells, compared to whole-tis-
sue expression analyses (Stone et al. 1992). We also stud-
ied human rather than animal cells. The volume of data
offered by our genome-wide approach revealed several
ATII cell adaptations to both inflammation and MSCs,
which sets the stage for mechanistic experiments.
The limitations to these studies include the in vitro
approach, the modest sample size, the lack of an MSC-only
group, and the reliance on gene expression analyses. The
in vitro Transwell model has been useful in studies of alve-
olar cell protein permeability (Fang et al. 2010), alveolar
fluid clearance (Lee et al. 2007), and interactions with
MSCs (Fang et al. 2010, 2015). In addition, the proinflam-
matory cytokines in this study reproduce many of the
effects of pulmonary edema fluid from ARDS patients (Lee
et al. 2007), and in vivo experiments have generated com-
plementary results to Transwell experiments (Fang et al.
2015). However, the environment encountered by ATII
cells in vivo is more complex, with inflammatory cells,
endothelial cells, and lymphatics, which were not
accounted for in this study. In the future, the genes identi-
fied here as upregulated by ATII cells in response to MSCs
could be inhibited in in vivo models of lung injury to con-
firm that these genes indeed mediate the protective effect
of MSCs in vivo. Although the sample size is limited, we
were able to discover statistically significantly differentially
expressed genes that had at least twofold change across bio-
logical replicates of ATII cells. Because we did not have a
group of MSC-only condition, we could not distinguish
the effects of MSCs on ATII cells from the interaction of
MSCs and CytoMix on ATII cells. However, the compar-
ison of MSCs plus an inflammatory environment versus
the inflammatory environment alone is the most clinical
relevant comparison and has been previously used (dos
Santos et al. 2012). Lastly, our study only explored mRNA
expression changes, and future studies could include
protein or micro RNA studies to further validate and
explore these changes induced by MSCs.
This study shows that exposure to an acute inflamma-
tory environment induces ATII cells to upregulate genes
that code cytokines and downregulate those associated
with alveolar fluid clearance and surfactant. Exposure to
MSCs partially reversed several of these changes.
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